PureTech Health plc (NASDAQ:PRTC – Get Free Report) rose 2.5% during trading on Monday . The stock traded as high as $18.53 and last traded at $18.25. Approximately 3,307 shares traded hands during mid-day trading, an increase of 30% from the average daily volume of 2,553 shares. The stock had previously closed at $17.80.
PureTech Health Stock Up 2.5 %
The firm has a 50 day simple moving average of $18.55 and a 200 day simple moving average of $20.20.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in PureTech Health stock. Millennium Management LLC bought a new position in PureTech Health plc (NASDAQ:PRTC – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 45,264 shares of the company’s stock, valued at approximately $823,000. Millennium Management LLC owned 0.19% of PureTech Health as of its most recent SEC filing. Institutional investors own 0.04% of the company’s stock.
About PureTech Health
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Featured Stories
- Five stocks we like better than PureTech Health
- How to start investing in penny stocks
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Short Selling: How to Short a Stock
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- Market Cap Calculator: How to Calculate Market Cap
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
